TriHealth is notifying individuals whose information was involved in a recent third-party data security incident. Click here for more information.
As national leaders in robotic-assisted mitral valve repair, our surgeons have extensive experience in heart valve repair and replacement. In fact, we have a case volume that ranks among the top five in the country.
We are also one of the first hospitals in the United States – and one of four in Ohio – to offer transcatheter aortic valve replacement (TAVR).
When a heart valve is not working, cardiac surgery is often used to replace or repair the diseased valve. Repairing a heart valve, when possible, is often preferable to replacement, as there is a reduced risk of complications.
Patient outcomes tell the story in this comparison against top-performing, non-robotic peers*.
*Premier Quality Advisor – CareScience CY14 Top Performing Cohort for all outcomes
The best available surgical treatment for mitral valve disease is valve repair. Valve repair involves the surgeon reconstructing your valve using your own tissues. Valve repair offers a number of significant, life-long benefits compared to valve replacement. These include a lower risk of mortality, a better chance of long-term survival and more freedom from re-operation. Our surgeons repair rather than replace the mitral valve in 90 percent of cases, outpacing the national average of 60 percent repairs. Best of all, at our Heart Institute, valve repair generally can be done using robotic-assisted surgery.
Robotic-assisted mitral valve surgery is an alternative to conventional open heart surgery, giving our patients a less invasive treatment option. Traditional open heart surgery involves sternotomy – cutting through the breastbone and opening the ribs. Sternotomy can cause significant trauma, prolong healing time, and increase the risk for serious complications – even resulting in mortality. Moreover, an open approach doesn’t always provide the visualization and access necessary to complete a repair.
In addition to avoiding the pain and trauma of sternotomy and rib spreading, this may provide patient benefits such as:
Over five years, our Institute’s observed mortality rate for mitral valve replacement and repair, plus bypass is 0 percent, which is better than 92.5 percent of hospitals nationally. The observed mortality for aortic valve replacement is 1.6 percent, which is better than 93.5 percent of hospitals nationally.
Up to 1.5 million people in the United States suffer from aortic stenosis, a progressive disease that causes narrowing or obstruction of the aortic valve. We are one of the first hospitals in the U.S. to offer transcatheter aortic valve replacement (TAVR), for patients suffering from aortic stenosis. TAVR is a minimally invasive treatment option for those who are not candidates for open heart surgery. Learn more.
As with any surgery, these benefits cannot be guaranteed, as surgery is both patient- and procedure-specific. While robotic-assisted mitral valve surgery is considered safe and effective, it may not be appropriate for every individual. Always ask your doctor about all treatment options, as well as their risks and benefits.